Tissue Therapies Limited (ASX:TIS) Change in Strategy and Development of VitroGro as a Pharmaceutical Worldwide
Tissue Therapies (ASX:TIS), a biomedical technology company developing effective treatments for wound healing, today announces its intention to develop VitroGro(R) ECM as a pharmaceutical worldwide for wound healing, and approval will be concurrently sought from the United States Food and Drug Administration (FDA) and the European Medicines Agency (EMA).